Eton Pharmaceuticals (ETON) Invested Capital (2019 - 2025)
Eton Pharmaceuticals (ETON) has disclosed Invested Capital for 7 consecutive years, with $34.9 million as the latest value for Q4 2025.
- Quarterly Invested Capital fell 35.58% to $34.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.9 million through Dec 2025, down 35.58% year-over-year, with the annual reading at $34.9 million for FY2025, 35.58% down from the prior year.
- Invested Capital hit $34.9 million in Q4 2025 for Eton Pharmaceuticals, up from $25.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $54.4 million in Q1 2025 to a low of $15.5 million in Q4 2023.
- Historically, Invested Capital has averaged $25.1 million across 5 years, with a median of $21.1 million in 2021.
- Biggest five-year swings in Invested Capital: surged 250.45% in 2024 and later plummeted 35.58% in 2025.
- Year by year, Invested Capital stood at $22.9 million in 2021, then dropped by 19.35% to $18.5 million in 2022, then decreased by 16.17% to $15.5 million in 2023, then soared by 250.45% to $54.2 million in 2024, then tumbled by 35.58% to $34.9 million in 2025.
- Business Quant data shows Invested Capital for ETON at $34.9 million in Q4 2025, $25.9 million in Q3 2025, and $26.7 million in Q2 2025.